A Study of TQ05105 Tablets in Subjects With Myeloproliferative Neoplasms
Clinical trial NCT04339400 · COMPLETED
Trial details
- NCT number
- NCT04339400
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-20
- Primary completion
- 2023-03-17
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.